Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Bellone

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Molecular Cancer Therapeutics|December 17, 2016
Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-βElena Jachetti, Alice Rigoni, Lucia Bongiovanni, et al.
Cancer Immunology, Immunotherapy : CII|November 10, 2021
Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11-13 2019, Verona, ItalyMatteo Bellone, Marco Bregni, Vincenzo Bronte, et al.
Oncoimmunology|July 9, 2015
Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myelomaArianna Calcinotto, Maurilio Ponzoni, Roberto Ria, et al.
Cancer Research|March 27, 2015
Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell ActivationElena Jachetti, Sara Caputo, Stefania Mazzoleni, et al.
Frontiers in Oncology|October 29, 2021
[<sup>18</sup>F](2<i>S</i>,4<i>R</i>)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in MyelomaSilvia Valtorta, Denise Toscani, Martina Chiu, et al.
Frontiers in Immunology|October 5, 2020
Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early MetastasisSara Caputo, Matteo Grioni, Chiara S Brambillasca, et al.
European Urology Focus|July 30, 2017
PD-L1 Expression and CD8<sup>+</sup> T-cell Infiltrate are Associated with Clinical Progression in Patients with Node-positive Prostate CancerFlorent Petitprez, Nicola Fossati, Yann Vano, et al.
Cell Reports|March 15, 2018
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer ProgressionFilippo Cortesi, Gloria Delfanti, Andrea Grilli, et al.
Cancer Research|May 18, 2012
Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytesArianna Calcinotto, Paola Filipazzi, Matteo Grioni, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2020
Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, ItalyMatteo Bellone, Arianna Brevi, Stefania Bruzzì, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Molecular Cancer Therapeutics|December 17, 2016
Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-βElena Jachetti, Alice Rigoni, Lucia Bongiovanni, et al.
Cancer Immunology, Immunotherapy : CII|November 10, 2021
Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11-13 2019, Verona, ItalyMatteo Bellone, Marco Bregni, Vincenzo Bronte, et al.
Oncoimmunology|July 9, 2015
Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myelomaArianna Calcinotto, Maurilio Ponzoni, Roberto Ria, et al.
Cancer Research|March 27, 2015
Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell ActivationElena Jachetti, Sara Caputo, Stefania Mazzoleni, et al.
Frontiers in Oncology|October 29, 2021
[<sup>18</sup>F](2<i>S</i>,4<i>R</i>)-4-Fluoroglutamine as a New Positron Emission Tomography Tracer in MyelomaSilvia Valtorta, Denise Toscani, Martina Chiu, et al.
Frontiers in Immunology|October 5, 2020
Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early MetastasisSara Caputo, Matteo Grioni, Chiara S Brambillasca, et al.
European Urology Focus|July 30, 2017
PD-L1 Expression and CD8<sup>+</sup> T-cell Infiltrate are Associated with Clinical Progression in Patients with Node-positive Prostate CancerFlorent Petitprez, Nicola Fossati, Yann Vano, et al.
Cell Reports|March 15, 2018
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer ProgressionFilippo Cortesi, Gloria Delfanti, Andrea Grilli, et al.
Cancer Research|May 18, 2012
Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytesArianna Calcinotto, Paola Filipazzi, Matteo Grioni, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2020
Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, ItalyMatteo Bellone, Arianna Brevi, Stefania Bruzzì, et al.
Pageof 9